Please find enclosed the Standalone Unaudited Financial Results for the quarter and half year ended 30th September, 2025 along with the Limited Review report of the Statutory Auditors as ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMC Speciality Hospitals reported strong Q2 FY26 results with revenue from operations of Rs 7,490.19 lakhs, up about 33% YoY from Rs 5,623.07 lakhs. For H1 FY26, revenue rose to Rs 14,145.48 lakhs vs Rs 10,929.87 lakhs in H1 FY25. Profit after tax jumped to Rs 1,084.11 lakhs in Q2 from Rs 388.41 lakhs a year ago, with H1 PAT nearly doubling to Rs 1,837.62 lakhs. EBITDA margins expanded meaningfully as operating leverage kicked in, with finance costs also declining. Operating cash flow for H1 was robust at Rs 3,067.68 lakhs, and cash and bank balances rose sharply to Rs 2,387.71 lakhs. Statutory auditors Deloitte Haskins & Sells issued an unmodified (clean) limited review report.
Strong revenue and PAT growth, combined with margin expansion and healthy cash generation, signal a positive quarter for shareholders. The clean auditor review with no qualifications further supports confidence in the reported numbers; expect positive sentiment in the stock.